2015
DOI: 10.1039/c4bm00459k
|View full text |Cite
|
Sign up to set email alerts
|

Engineering DNA scaffolds for delivery of anticancer therapeutics

Abstract: Engineering DNA nanostructures with programmability in size, shape and surface chemistry holds tremendous promise in biomedical applications. As an emerging platform for drug delivery, DNA nanostructures have been extensively studied for delivering anticancer therapeutics, including small-molecule drug, nucleic acids and proteins. In this mini-review, current advances in utilizing DNA scaffolds as drug carriers for cancer treatment were summarized and future challenges were also discussed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
24
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 60 publications
(24 citation statements)
references
References 77 publications
0
24
0
Order By: Relevance
“…Therefore, developing the different delivery systems which can target cancer cells either actively or passively, thereby reducing adverse side effects to the normal tissues, is desirable [67]. Recently, a variety of delivery systems with improved therapeutic efficacy have developed due to the understanding of the tumor biology and developing versatile materials with increased bioavailability such as polymers [68][69][70], lipids [71,72], polymeric hydrogels [73,74], inorganic carriers [75], and biomacromolecular scaffolds [76]. The entrance of the nanotechnology in the field of the clinical therapeutics has had grate impact during the last two decades.…”
Section: Alginate Applicationsmentioning
confidence: 99%
“…Therefore, developing the different delivery systems which can target cancer cells either actively or passively, thereby reducing adverse side effects to the normal tissues, is desirable [67]. Recently, a variety of delivery systems with improved therapeutic efficacy have developed due to the understanding of the tumor biology and developing versatile materials with increased bioavailability such as polymers [68][69][70], lipids [71,72], polymeric hydrogels [73,74], inorganic carriers [75], and biomacromolecular scaffolds [76]. The entrance of the nanotechnology in the field of the clinical therapeutics has had grate impact during the last two decades.…”
Section: Alginate Applicationsmentioning
confidence: 99%
“…Future implementation of the delivery vehicles may focus on attaching cell-specific targeting ligands, [22] engineering the environmentally responsive release of CRISPR-Cas9, [14,23] modifying the sequence of the DNAN Cs to incorporate multiple sgRNAs for multiplex editing,o re mploying the DNAN Cs or packaged DNAs equences as templates for homology-directed repair.T he same NC architecture could also be used to incorporate other functional DNA-binding proteins,s uch as transcription factors,z inc-finger nucleases, and TALE nucleases,a sw ell as other functional or proteincoding RNAs.T he potential immunogenicity associated with DNAn anoclews should be further investigated for clinical translation. [24]…”
Section: Angewandte Chemiementioning
confidence: 99%
“…The potential immunogenicity associated with DNA NCs should be further investigated for clinical translation. [24] …”
mentioning
confidence: 99%